Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Market Cap
$158.88M
P/E Ratio
-2.25
1Y Stock Return
-73.60%
1Y Revenue Growth
-0.87%
Dividend Yield
0.00%
Price to Book
0.6
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
Nevro unveils publication of positive data study regarding its Nevro1 SI Joint Fusion System.
Yahoo
Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.
Yahoo
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data in Medical Devices: Evidence and Research, which demonstrate the superiority of the Nevro1™ SI Joint Fusion System ("Nevro1"), a posterior integrated transfixation cage system offering enhanced stability, minimized bone removal and increased fusion potential compared to a posterolateral cylindrical threa
Yahoo
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on November 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 37,726 shares of Nevro's common stock to 24 new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan a
Yahoo
NVRO's HFX iQ SCS system receives CE Mark Certification in Europe. Nevro expects to begin launching HFX iQ in select European countries from the first quarter of 2025.
Yahoo
Nevro Corp. ( NYSE:NVRO ) just released its latest quarterly results and things are looking bullish. Results overall...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LPLA | -0.07% | $23.55B | +38.13% | 0.38% |
HIHO | -0.14% | $8.63M | 0.00% | 6.12% |
EPM | 0.14% | $198.21M | +0.68% | 8.19% |
CEVA | 0.15% | $668.16M | +27.56% | 0.00% |
CCEC | -0.16% | $1.02B | +28.03% | 3.26% |
MNR | 0.22% | $1.66B | -10.71% | 15.90% |
XBIO | -0.43% | $6.01M | +21.36% | 0.00% |
LPTH | 0.45% | $62.27M | +33.05% | 0.00% |
ZCMD | -0.49% | $2.80M | -88.67% | 0.00% |
CASI | 0.57% | $71.56M | -6.32% | 0.00% |
ALAR | 0.57% | $89.09M | +158.08% | 0.00% |
SAVA | 0.61% | $1.35B | +25.50% | 0.00% |
AFL | 0.64% | $61.74B | +35.69% | 1.35% |
NNVC | 0.68% | $19.66M | +25.69% | 0.00% |
FWONA | 0.78% | $18.48B | +27.70% | 0.00% |
DOGZ | -0.79% | $614.77M | +1,372.26% | 0.00% |
TEO | 0.80% | $1.69B | +87.97% | 0.00% |
FATBB | -0.83% | $81.94M | -12.91% | 11.69% |
PRPO | 0.85% | $9.10M | -13.65% | 0.00% |
CTMX | 0.87% | $69.86M | -31.59% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FTNT | -29.32% | $69.59B | +72.67% | 0.00% |
MCK | -20.14% | $78.15B | +35.51% | 0.42% |
AXON | -17.76% | $46.53B | +167.14% | 0.00% |
REYN | -17.74% | $5.79B | +3.76% | 3.35% |
HUSA | -17.65% | $16.69M | -11.56% | 0.00% |
CBOE | -13.98% | $21.46B | +15.84% | 1.11% |
STG | -10.76% | $35.67M | +7.92% | 0.00% |
SMWB | -9.81% | $1.01B | +134.25% | 0.00% |
DT | -9.67% | $15.40B | -1.30% | 0.00% |
TPST | -9.53% | $37.75M | -77.59% | 0.00% |
RYAM | -9.52% | $596.54M | +189.14% | 0.00% |
RLMD | -8.39% | $89.92M | +1.36% | 0.00% |
PRT | -7.99% | $48.72M | -16.56% | 10.33% |
CME | -7.36% | $82.76B | +9.21% | 1.98% |
RVLV | -7.00% | $2.35B | +127.64% | 0.00% |
SU | -6.62% | $52.05B | +23.58% | 3.92% |
BROS | -6.43% | $5.67B | +74.77% | 0.00% |
PGR | -6.35% | $149.10B | +57.29% | 0.45% |
LITB | -5.94% | $35.48M | -75.45% | 0.00% |
HDSN | -5.55% | $260.34M | -54.39% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TBIL | 0.21% | $4.38B | 0.15% |
WEAT | -0.23% | $120.27M | 0.28% |
DBMF | -0.25% | $1.02B | 0.85% |
CLOI | -1.40% | $715.40M | 0.4% |
KRBN | -2.10% | $242.47M | 0.85% |
AGZD | -2.28% | $142.76M | 0.23% |
DXJ | 2.44% | $3.71B | 0.48% |
SMB | 2.44% | $266.77M | 0.07% |
HDRO | -2.50% | $164.26M | 0.3% |
XHLF | -2.71% | $874.27M | 0.03% |
BOXX | 2.86% | $4.43B | 0.1949% |
FLJH | 2.93% | $74.69M | 0.09% |
IBHD | 2.95% | $327.80M | 0.35% |
UNG | -3.16% | $908.80M | 1.06% |
DBJP | 3.20% | $399.93M | 0.45% |
HEWJ | 3.36% | $347.32M | 0.5% |
DBA | -3.54% | $755.88M | 0.93% |
PREF | 3.67% | $999.92M | 0.55% |
JUCY | -3.91% | $324.29M | 0.6% |
DBO | 4.08% | $217.57M | 0.77% |
Current Value
$4.211 Year Return
Current Value
$4.211 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ODP | 60.34% | $777.35M | -46.62% | 0.00% |
TREX | 55.55% | $7.22B | -0.22% | 0.00% |
AZTA | 48.94% | $2.00B | -28.24% | 0.00% |
EYE | 47.32% | $888.30M | -42.18% | 0.00% |
TDOC | 47.05% | $1.54B | -47.22% | 0.00% |
VVV | 46.60% | $4.98B | +11.54% | 0.00% |
MBC | 46.29% | $2.11B | +28.58% | 0.00% |
EVCM | 44.81% | $2.06B | +33.33% | 0.00% |
QLYS | 44.47% | $5.18B | -21.75% | 0.00% |
NRC | 44.47% | $442.05M | -55.00% | 2.56% |
IMXI | 44.36% | $651.21M | -1.55% | 0.00% |
ICUI | 44.28% | $4.15B | +104.38% | 0.00% |
TECH | 44.00% | $10.55B | +4.49% | 0.48% |
NVST | 43.80% | $3.49B | -15.41% | 0.00% |
CNDT | 43.66% | $569.21M | +20.27% | 0.00% |
PHR | 43.42% | $1.07B | +20.61% | 0.00% |
ALGT | 43.22% | $1.30B | +5.00% | 1.70% |
GPRO | 43.13% | $179.52M | -67.23% | 0.00% |
SIBN | 42.77% | $516.68M | -29.40% | 0.00% |
CLDT | 42.75% | $425.53M | -12.03% | 3.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 59.24% | $213.41M | 0.35% |
EDOC | 49.99% | $40.86M | 0.68% |
RSPA | 49.88% | $273.87M | 0% |
PRFZ | 49.81% | $2.65B | 0.39% |
XSVM | 49.54% | $853.92M | 0.37% |
GSSC | 49.52% | $529.86M | 0.2% |
IWM | 49.40% | $75.73B | 0.19% |
IWO | 49.22% | $12.56B | 0.24% |
VTWO | 49.17% | $12.38B | 0.1% |
XSMO | 48.99% | $1.25B | 0.39% |
IJT | 48.97% | $6.64B | 0.18% |
SPSM | 48.91% | $12.72B | 0.03% |
IJR | 48.76% | $90.05B | 0.06% |
VIOO | 48.74% | $3.12B | 0.1% |
ICVT | 48.51% | $2.44B | 0.2% |
SMMD | 48.25% | $1.24B | 0.15% |
KOMP | 48.24% | $2.09B | 0.2% |
IWC | 48.18% | $933.99M | 0.6% |
IWR | 48.13% | $39.67B | 0.19% |
TMSL | 48.10% | $288.12M | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -38.52% | $388.04M | 1.43% |
USDU | -24.34% | $201.97M | 0.5% |
UUP | -21.67% | $309.25M | 0.77% |
VIXY | -19.72% | $195.31M | 0.85% |
ULST | -16.58% | $535.47M | 0.2% |
TAIL | -14.94% | $67.98M | 0.59% |
EQLS | -12.15% | $76.08M | 1% |
KMLM | -11.14% | $353.87M | 0.9% |
HIGH | -10.61% | $302.78M | 0.51% |
CTA | -9.07% | $350.27M | 0.78% |
FMF | -4.18% | $244.61M | 0.95% |
KCCA | -4.11% | $220.51M | 0.87% |
JUCY | -3.91% | $324.29M | 0.6% |
DBA | -3.54% | $755.88M | 0.93% |
UNG | -3.16% | $908.80M | 1.06% |
XHLF | -2.71% | $874.27M | 0.03% |
HDRO | -2.50% | $164.26M | 0.3% |
AGZD | -2.28% | $142.76M | 0.23% |
KRBN | -2.10% | $242.47M | 0.85% |
CLOI | -1.40% | $715.40M | 0.4% |